Rare diseases
Investigational molecules
Locations
Via Palermo 26 A, 43122 Parma, Italy
Chiesi Farmaceutici S.p.A. is active in clinical research for asthma, including uncontrolled asthma, mild to moderate asthma, and moderate to severe controlled asthma. Its studies also address asthma exacerbations, lung function, and symptom control in patients receiving inhaled maintenance therapy.
The sponsor’s respiratory portfolio includes work on inhaled treatments for persistent airway disease and the optimization of combination inhaler approaches in patients with chronic respiratory symptoms.
Chiesi Farmaceutici S.p.A. runs clinical trials in conditions such as Asthma, Chronic obstructive pulmonary disease, Fabry's disease, Partial lipodystrophy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Bulgaria
Austria
FranceBulgariaAustria
Belgium
GermanyAustriaAustriaBulgariaBulgariaBulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
